NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
In the past 30 years, the population of prisoners in the United States has expanded more than 4.5 fold, correctional facilities are increasingly overcrowded, and more of the country’s disadvantaged populations—racial minorities, women, people with mental illness, and people with communicable diseases such as human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), hepatitis C, and tuberculosis—are under correctional supervision. Because prisoners face restrictions on liberty and autonomy, limited privacy, and often inadequate health care, they require specific protections when involved in research, particularly in today’s correctional settings. Given these issues, the Department of Health and Human Services (DHHS) Office for Human Research Protections (OHRP) commissioned the Institute of Medicine (IOM) to review the ethical considerations regarding research involving prisoners. The resulting analysis emphasizes five broad actions to provide prisoners involved in research with critically important protections: (1) expand the definition of the term prisoner; (2) ensure universally and consistently applied standards of protection; (3) shift from a category-based to a risk-benefit approach to research review; (4) update the ethical framework to include collaborative responsibility; and (5) enhance systematic oversight of research involving prisoners.
Contents
- The National Academies
- Committee on Ethical Considerations for Revisions to DHHS Regulations for Protection of Prisoners Involved in Research
- Board on Health Sciences Policy
- Independent Report Reviewers
- Preface
- Acronyms
- Summary
- 1. Introduction
- 2. Today’s Prisoners: Changing Demographics, Health Issues, and the Current Research Environment
- 3. Federal Regulatory Landscape
- 4. Defining Prisoners and Correctional Settings
- 5. The Ethical Framework for Research Involving Prisoners
- 6. Systems of Oversight, Safeguards, and Protections
- OVERARCHING PRINCIPLE
- DEFINING AND REVIEWING PRISONER RESEARCH
- SYSTEMATIC OVERSIGHT OF RESEARCH WITH PRISONERS
- APPLYING SAFEGUARDS FOR PARTICULAR KINDS OF RESEARCH
- OTHER CATEGORIES AND TYPES OF RESEARCH INVOLVING PRISONERS PROHIBITED
- IMPACT OF COMMITTEE RECOMMENDATIONS ON STAKEHOLDER RESPONSIBILITIES
- REFERENCES
- Appendixes
- A Data Sources and Methods
- B The National Commission’s Deliberations and Findings
- C Report of the SACHRP Subcommittee and Human Subjects Protections
- D Code of Federal Regulations Title 45: Public Welfare Part 46: Protection of Human Subjects
- E Committee, Expert Advisor, Liaison Panel, and Staff Biographies
This study was supported by Award No. N01-OD-4-2139, TO #149 (DHHS-5294-249) between the National Academy of Sciences and the DHHS (Office for Human Research Protections)/National Institutes of Health and by a grant from The Greenwall Foundation. Any opinions, findings, or conclusions expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
- NLM CatalogRelated NLM Catalog Entries
- Knowledge of Federal Regulations for Mental Health Research Involving Prisoners.[AJOB Empir Bioeth. 2015]Knowledge of Federal Regulations for Mental Health Research Involving Prisoners.Johnson ME, Brems C, Bergman AL, Mills ME, Eldridge GD. AJOB Empir Bioeth. 2015; 6(4):12-18. Epub 2014 Dec 17.
- IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.[AIDS Read. 2001]IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.Cohen J, Division of Human Subject Protection, Office for Human Research Protection, Rockville, Md. AIDS Read. 2001 Jan; 11(1):41-2.
- Review Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses[ 2014]Review Evidence Brief: The Quality of Care Provided by Advanced Practice NursesMcCleery E, Christensen V, Peterson K, Humphrey L, Helfand M. 2014 Sep
- HIV/AIDS research in correctional settings: perspectives on training needs from researchers and IRB members.[AIDS Educ Prev. 2014]HIV/AIDS research in correctional settings: perspectives on training needs from researchers and IRB members.Kondo KK, Johnson ME, Ironside EF, Brems C, Eldridge GD. AIDS Educ Prev. 2014 Dec; 26(6):565-76.
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.[Cochrane Database Syst Rev. 2022]Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, et al. Cochrane Database Syst Rev. 2022 Feb 1; 2(2022). Epub 2022 Feb 1.
- Ethical Considerations for Research Involving PrisonersEthical Considerations for Research Involving Prisoners
Your browsing activity is empty.
Activity recording is turned off.
See more...